Biohaven (BHVN) Capital Expenditures (2021 - 2026)
Biohaven's Capital Expenditures came in at $454,000 for Q2 2026, up 94.8% from $233,000 a year earlier.
Powered by 
Analysis
Biohaven (BHVN) Capital Expenditures (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biohaven reported Capital Expenditures of $475,000, down 64.9% year-over-year; for FY2025, it was $715,000, down 82.3% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of -14.9% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $4.05 million in FY2024 (+32.8%), $3.05 million in FY2023 (-49.8%), $6.07 million in FY2022 (+547.5%) and $938,000 in FY2021 (-41.4%).
- The Q2 2026 figure represents the highest quarterly Capital Expenditures since Q1 2025.
- Year-over-year, Capital Expenditures increased in two of the last seven quarters, with an average decline of 44.9%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q2 2024 (growth of 395.6%), and the weakest in Q3 2025 (a decline of 97.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Biohaven | 2.01 Bn | 819.54 Mn | - | 454,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 454,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 233,000.00 |
| Mar 31, 2025 | 461,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 611,000.00 |
| Jun 30, 2024 | 2.95 Mn |
| Mar 31, 2024 | 440,000.00 |
| Dec 31, 2023 | 470,000.00 |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 595,000.00 |
| Mar 31, 2023 | 735,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 4.52 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 246,000.00 |
| Dec 31, 2021 | 201,000.00 |
API Access
Biohaven Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BHVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "BHVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BHVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();